↑

International Patients: +91 8743024344 · Indian Patients: +91 7838223336 · Patient Reviews · Leave a Google Review ★

Ankylosing Spondylitis · Stem Cell Therapy

Ankylosing Spondylitis Stem Cell Treatment in Delhi, India

Stem cell therapy for Ankylosing Spondylitis is an investigational approach being studied alongside standard medical care, with potential benefits varying depending on the type and severity of the injury.

Get Free Medical Evaluation → · Upload Medical Reports → · Latest Blog on Ankylosing Spondylitis →

10,000+ patients treated worldwide
Stem Cell Care India doctor reviewing before-and-after brain scans on a tablet with a patient and family member during a ankylosing spondylitis stem cell therapy consultation
10,000+ Patients treated
65+ Countries served
Certified Accredited hospitals & labs
16+ Years GMP-certified cell processing

Quick Answer

Ankylosing spondylitis (AS) already has effective standard treatments, particularly biologic medications (TNF inhibitors and IL-17 inhibitors), which most patients should try first. Small clinical studies (including reports of umbilical cord MSC infusion in a handful of patients) suggest MSC therapy may be safe and could reduce disease activity scores, and there is a growing preclinical/mechanistic research base. However, the human clinical evidence remains limited to small, mostly uncontrolled studies, so this should be seen as an emerging area, not an established treatment.

Key Takeaways

On this page — 6 categories, 27 topics

01

What Stem Cell Therapy for Ankylosing Spondylitis Is

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and, over time, potential fusion of spinal vertebrae in severe cases. It falls within a family of conditions called spondyloarthropathies and is closely linked to the HLA-B27 gene.

Modern treatment, especially biologic medications, has dramatically improved outcomes for many AS patients compared to a generation ago, which is an important context for evaluating any newer, less-established option like stem cell therapy.

Do You Know about Ankylosing Spondylitis?

AS is strongly associated with the HLA-B27 gene, though not everyone with this gene develops the condition, and not everyone with AS carries it. This genetic and immune-system link is part of why researchers are interested in immune-modulating therapies like MSCs for this condition.

02

Symptoms of Ankylosing Spondylitis

Ankylosing spondylitis symptoms typically develop gradually and include:

  • Chronic lower back and hip pain and stiffness, often worse in the morning or after inactivity
  • Pain that improves with movement but returns with rest
  • Fatigue
  • Reduced spinal flexibility over time
  • Eye inflammation (uveitis) in some patients
  • Pain in other joints, such as the shoulders, knees, or ankles
03

Causes of Ankylosing Spondylitis

Ankylosing spondylitis develops from a combination of genetic and immune factors:

  • HLA-B27 Gene: Strongly associated with AS, though not the sole cause.
  • Family History: Having a close relative with AS increases risk.
  • Immune Dysregulation: Excess inflammatory signaling (particularly involving TNF and IL-17 pathways) drives joint and spinal inflammation.
  • Gut Microbiome Factors: Emerging research suggests a possible link between gut bacteria and AS risk, though this is still being studied.
04

How Ankylosing Spondylitis Is Diagnosed

Diagnosing AS typically involves:

  • Clinical History and Exam: Assessing pattern, duration, and character of back pain and stiffness.
  • HLA-B27 Genetic Testing: Supports diagnosis, though a positive result alone doesn't confirm AS.
  • Inflammatory Markers: ESR and CRP blood tests to assess systemic inflammation.
  • Imaging (X-ray/MRI): MRI can detect early sacroiliac joint inflammation before changes are visible on X-ray.
05

How Stem Cell Therapy Is Approached as a Treatment for Ankylosing Spondylitis

Current Standard of Care

First-line treatment includes NSAIDs and physical therapy/exercise. For patients with inadequate response, biologic medications (TNF inhibitors like adalimumab, or IL-17 inhibitors like secukinumab) are highly effective for many patients and are considered the standard of care for moderate-to-severe disease.

Where Stem Cell Research Fits In

For patients who don't respond adequately to biologic therapy, or who want to explore additional options, small studies have investigated umbilical cord or bone marrow-derived MSC infusion, generally reporting good tolerability and reductions in AS disease activity indices. This remains an emerging research area that should complement, not replace, standard biologic treatment for most patients.

06

How It's Being Explored for Ankylosing Spondylitis

A published report described umbilical cord MSC infusion in five AS patients (four male, one female, ages 17-44), given via intravenous infusion, with no severe adverse reactions observed and suggested potential as an alternative treatment option, while noting study limitations and the need for further research.

A broader review of MSCs in ankylosing spondylitis discusses recent findings of clinical trials involving MSC therapy in AS and notes that additional studies are required to investigate features such as cell origin, dosage, and administration route.

A systematic review and meta-analysis of randomized controlled trials evaluated MSC transplantation across several autoimmune diseases including AS, rheumatoid arthritis, lupus, inflammatory bowel disease, and multiple sclerosis.

07

What the Ankylosing Spondylitis Treatment Process Looks Like

Day 1

  • Pick-up from the airport to the hospital
  • Initial consultation between doctor and patient to address any questions
  • Admission formalities
  • Clinical examination and lab tests as prescribed by the doctor
  • Supportive therapy

Day 2

  • Stem cell procedure
  • Supportive therapies
  • Physiotherapy, as appropriate

Day 3

  • Supportive therapy
  • Discharge formalities
  • Drop-off at the airport

Note: For admission, patients should carry valid identification (passport, PAN card, or driving license) along with hard copies of relevant medical records and prior test results.

08

Delivery Techniques Used in Stem Cell Therapy for Ankylosing Spondylitis

Depending on the treatment plan, stem cells may be administered using one or more of the following methods:

  • Intravenous infusion (the method used in the small published human studies)
09

Is Stem Cell Therapy Safe for Ankylosing Spondylitis?

Stem cell therapy for Ankylosing Spondylitis is discussed only after an individual medical evaluation, and safety depends heavily on that case-by-case review rather than on the therapy in general. As with any medical intervention, mild and temporary reactions (such as soreness or fatigue at the injection or infusion site) are possible, and a full risk discussion happens as part of your evaluation. It is not offered to patients in an acute or unstable phase of Ankylosing Spondylitis, and it is never positioned as a substitute for guideline-based care from your treating specialist. For a fuller picture of how safety, accreditation, and quality standards are handled, see our Safety and Guarantees page.

10

Who Might Consider a Ankylosing Spondylitis Discussion — and Who Should Not

May be reasonable to discuss

  • A confirmed ankylosing spondylitis diagnosis, with the patient medically stable and not in an acute emergency
  • Prior imaging, neurology, and treatment records available for review
  • The injury is past its acute phase, with the patient in a stable, chronic-care stage
  • Realistic expectations that any benefit would be supportive and investigational, not a cure
  • Willingness to continue rehabilitation and follow-up care alongside this discussion

Generally not appropriate

  • Acute or unstable neurological emergencies requiring immediate critical care
  • Active untreated infection, uncontrolled bleeding disorder, or advanced organ failure
  • An active, untreated malignancy that has not been cleared by an oncologist
  • Pregnancy, or an expectation that the therapy will reverse or cure the underlying condition
  • Unwillingness to share prior medical records or to be evaluated before proceeding

This list is general and educational — it is not a substitute for an individual medical evaluation of your case.

11

What a Ankylosing Spondylitis Supportive-Care Discussion Involves

A supportive-care discussion for Ankylosing Spondylitis isn't a single conversation — it follows a defined sequence, so nothing is recommended before your specific case has been reviewed. In broad terms:

  1. Record review: Your existing diagnosis, imaging, lab work, and treatment history for Ankylosing Spondylitis are reviewed by the medical team first.
  2. Case-by-case medical evaluation: A physician assesses whether any further discussion is medically reasonable for your specific case — many enquiries end here with a clear "not appropriate" answer, which is a valid and expected outcome.
  3. Coordination with your specialist: Where a discussion proceeds, it is coordinated so it does not conflict with your ongoing care from your treating specialist.
  4. Transparent, written explanation: Any recommendation is explained in plain language, including its investigational status, realistic expectations, and that no outcome is guaranteed.
  5. Ongoing standard care continues: At every stage, your prescribed treatment for Ankylosing Spondylitis continues unless your own treating specialist changes it.

Nothing is scheduled or billed during this stage — it is a review and conversation, not a commitment.

12

Our Approach to Ankylosing Spondylitis Care

For AS patients, our first recommendation is to ensure standard treatment — including biologic medication if appropriate — has been fully explored with a rheumatologist. We present MSC therapy as an emerging, mechanistically plausible option with early positive signals, not as a substitute for established, more thoroughly proven treatments.

13

Cost and How Stem Cell Therapy Compares for Ankylosing Spondylitis

Cost varies by patient based on medical history, the number of sessions recommended, and diagnostic requirements. Because stem cell therapy is offered outside standard insurance-covered pathways in most countries, patients are encouraged to request a personalized quote and to independently verify what is and is not included (consultation, cell processing, hospital stay, and follow-up).

14

Why Ankylosing Spondylitis Patients Consider Treatment in India

Considerations for patients weighing this option:

  • Mechanistically Plausible: MSCs' immune-modulating properties are directly relevant to an inflammatory, autoimmune-linked condition like AS.
  • Encouraging Early Signals: Small human studies report good tolerability and improved disease activity scores.
  • Still Early-Stage: Human evidence is limited to small, largely uncontrolled studies; larger RCTs are needed.
  • Best as a Complement: Should be considered alongside, not instead of, standard biologic therapy for most patients.
15

Quality Control in Cell Processing for Ankylosing Spondylitis Therapy

Stem Cell Care India applies standard laboratory safety and screening protocols to cell processing, including infectious disease screening, microbial contamination testing, and endotoxin testing, before any cell product is cleared for use. Patients are encouraged to ask for documentation of these safety checks and of the qualifications of the treating medical team.

16

What Ankylosing Spondylitis Patients May Notice After Treatment

Brain injuries can range from mild to severe, and outcomes after any treatment tend to reflect that range. The idea behind exploring stem cell approaches in this context is to support the brain's own capacity to begin repairing itself, in the hope of helping patients regain functions that might otherwise remain out of reach — though this is discussed as a possible supportive step, not a guaranteed one. Reported experiences following stem cell therapy for ankylosing spondylitis vary from patient to patient and depend on factors such as age and injury severity. Changes some patients have reported include:

  • Signs of repair in previously damaged brain tissue on follow-up assessment
  • Reduced swelling or inflammation
  • Changes in memory or thinking skills
  • Changes in movement, balance, or coordination
  • Changes in speech and communication
  • General alertness and activity levels
  • Support for the growth of new, healthy cells
  • A generally faster pace of the body's own natural healing

Stem cell therapy is not positioned as a permanent cure for ankylosing spondylitis, and any benefit may take time to appear or may not appear at all. It is generally discussed as a complement to, not a replacement for, other supportive therapies.

17

Quality Certification for Ankylosing Spondylitis Therapy

A quality certificate is intended to document that the cell-processing steps used for a given batch were carried out under stated laboratory protocols and that the resulting cells met the facility's internal quality checks. Stem Cell Care India states that its cell-processing procedures are documented in this way, that patients are not charged extra for this documentation, and that equipment used is checked ahead of each procedure.

The clinic describes this certification as reflecting ethical practice, with patient safety, informed consent, and clear information treated as priorities, alongside ongoing internal checks on quality and procedure. This documentation reflects internal laboratory quality assurance rather than a government approval of the therapy itself for curing Ankylosing Spondylitis, and a supporting team of medical staff is described as being available throughout the process.

18

Ankylosing Spondylitis Follow-Up Care

Patients are advised to continue regular rheumatology follow-up, including BASDAI/BASFI disease activity scoring and periodic imaging, to track disease progression regardless of which treatments are used.

19

Supportive Therapies Sometimes Used Alongside Ankylosing Spondylitis Treatment

Stem cell therapy is generally discussed as one part of a broader recovery plan rather than a stand-alone treatment. Supportive therapies sometimes used alongside it for ankylosing spondylitis include:

  • Psychological support: To help address mood changes, anxiety, or emotional stress that can follow a ankylosing spondylitis.
  • Speech therapy: For patients experiencing difficulty speaking, swallowing, or understanding language.
  • Physiotherapy: To help rebuild movement, balance, and muscle strength.
  • Hyperbaric oxygen therapy: Delivering oxygen at increased pressure, which is being explored as a supportive measure for tissue recovery.
  • Acupuncture: Used by some patients as a complementary approach alongside conventional care.
  • Rehabilitation therapy: Structured practice of daily tasks to support functional recovery.
  • Occupational therapy: Support for relearning tasks such as dressing, eating, and writing.
  • Nutrition therapy: Dietary guidance intended to support general recovery.
  • Nerve Growth Factor (NGF) treatment: Supports the survival and growth of nerve cells; when discussed alongside stem cell therapy, it is explored for its potential to support nerve repair and overall brain recovery.

Any combination of these should be planned together with the treating medical team rather than pursued independently.

20

Why Some International Ankylosing Spondylitis Patients Consider India

Patients travel to India from the USA, UK, Europe, the Gulf region, and elsewhere for a range of medical treatments, often citing cost and access to specialized centers as key factors.

What Brings International Patients to Choose India for Medical Treatments?

  • Specialized Centers: Hospitals maintain dedicated regenerative medicine departments with laboratory facilities.
  • Medical Visa Assistance: Support with medical visas and required travel documentation.
  • Airport Pickup and Drop: Airport transfer services on arrival and departure.
  • Multilingual Support: Interpreters and translators to support non-English-speaking patients.
  • Accommodation Support: In-house stays, guest houses, or hotel partnerships for comfortable lodging.
  • Cost: Generally lower than equivalent private care in the US, UK, or Western Europe, though patients should request itemized quotes.
21

Selected Ankylosing Spondylitis Research & Publications

Verified, publicly available research relevant to this topic includes:

  • Infusion of umbilical cord mesenchymal stem cells alleviates symptoms of ankylosing spondylitis. (Small study of 5 AS patients; reported general safety and symptom improvement.)
  • Abdolmohammadi K, et al. Ankylosing spondylitis and mesenchymal stromal/stem cell therapy: a new therapeutic approach. (Review of immunomodulatory mechanisms and clinical trial landscape.)
  • Efficacy and Safety of Mesenchymal Stem Cell Transplantation in the Treatment of Autoimmune Diseases (RA, SLE, IBD, MS, and AS): A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Readers should treat any additional named studies, institutions, or statistics cited elsewhere on this topic with caution unless they can be verified through PubMed, ClinicalTrials.gov, or the original journal.

22

Conclusion: Stem Cell Therapy for Ankylosing Spondylitis

Topic 22 of 22

Ankylosing spondylitis has benefited enormously from modern biologic therapies, which remain the strongest, most proven treatment option for most patients. Stem cell therapy is a genuinely interesting, mechanistically sound emerging research direction, with small studies suggesting safety and potential benefit.

Patients should ensure they've explored standard rheumatology care fully before considering MSC therapy, and should treat it as a complementary, still-developing option rather than a proven alternative.

Treatment Disclaimer: We provide consultation, case evaluation, and patient support services in the field of regenerative medicine. This page is for informational purposes and does not constitute medical advice or a guarantee of outcome.

Still deciding? ★★★★★ 4.9/5 from 193+ verified patients A free medical review shows whether it's worth pursuing for your specific case — no obligation.

Not sure if this applies to your case?

Share your diagnosis and reports, and our medical team will get back to you with a free, doctor-reviewed opinion on Ankylosing Spondylitis — no obligation.

  • Reviewed by our in-house medical team
  • Doctor-reviewed reply within 24–48 hours
  • No cost and no obligation to proceed
  • Your information is kept confidential

Get Your Free Evaluation

1. Your details 2. Your case
Common Questions

Frequently Asked Questions

No. Biologic medications have much stronger, larger-scale evidence for AS and are generally the appropriate next step if NSAIDs aren't enough.

Small studies (often just a handful of patients) report that MSC infusion is generally safe and associated with improved disease activity scores, but these studies are not large, randomized, or controlled.

Yes — MSCs' immune-modulating properties are mechanistically relevant to AS, and there is a growing preclinical and early clinical research base, but it is not yet a proven, established treatment.

Reported studies suggest general safety and tolerability, but as with any infusion-based therapy, individual risks should be discussed with your rheumatologist.

Not fully sure which diagnosis fits? Send both reports and our medical team will confirm which condition applies — often within 24–48 hours.

If a caregiver or patient you know is dealing with a different diagnosis, this covers the same treatment approach for another common condition:

All Treatments

Explore Other Categories

Editorial & Medical Standards

Medically reviewed by the Stem Cell Care India clinical team. Last reviewed 2 September 2026. Written by Nishat Arfin · Scientific review by Tabish Iqbal · Medically approved by the Stem Cell Care India Medical Team.


Talk to a case coordinator about your specific condition and treatment options.

24–48hFrom sending your reports to a doctor-reviewed answer
10,000+Patients treated across 65+ countries
4.9 / 5From 193+ verified Google reviews

Talk to a case coordinator about your specific condition and treatment options.

24–48hFrom sending your reports to a doctor-reviewed answer
10,000+Patients treated across 65+ countries
4.9 / 5From 196+ verified Google reviews

Patient stories — Orthopedic

Stem Cell Therapy for Ankylosing Spondylitis: Real Results & Patient Stories

Sri Lankan Patient – Cervical Spondylitis

Somnath Roy From Kolkata Came to Stem Cell Care India for Orthopedic Disorder

Patient With SLAP Right Shoulder Along With OA In Both Knee Joints Shares His Experience

See all patient videos →